BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23183445)

  • 21. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
    Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
    Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
    Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
    Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of triethyl citrate migration from coating polymers to tablet cores.
    Budavári Z; Porkoláb Z; Zelkó R
    Pharmazie; 2004 Nov; 59(11):893-4. PubMed ID: 15587596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dry coating: an innovative enteric coating method using a cellulose derivative.
    Obara S; Maruyama N; Nishiyama Y; Kokubo H
    Eur J Pharm Biopharm; 1999 Jan; 47(1):51-9. PubMed ID: 10234527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: Evaluation of film formulation and process set up.
    Albertini B; Bertoni S; Melegari C; Dolci LS; Passerini N
    Int J Pharm; 2017 Jan; 516(1-2):380-391. PubMed ID: 27894987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alginate-magnesium aluminum silicate films: effect of plasticizers on film properties, drug permeation and drug release from coated tablets.
    Pongjanyakul T; Puttipipatkhachorn S
    Int J Pharm; 2007 Mar; 333(1-2):34-44. PubMed ID: 17056214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
    Bhattacharjya S; Wurster DE
    AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of dynamic mechanical analysis (DMA) to evaluate plasticization of acrylic polymer films under simulated gastrointestinal conditions.
    Fadda HM; Khanna M; Santos JC; Osman D; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2010 Nov; 76(3):493-7. PubMed ID: 20800682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
    Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
    AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of plasticizers on the release of metoprolol tartrate from granules coated with a polymethacrylate film.
    Okarter TU; Singla K
    Drug Dev Ind Pharm; 2000 Mar; 26(3):323-9. PubMed ID: 10738649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of theophylline tablets dry powder coated with Eudragit((R)) E PO and Eudragit((R)) L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009 Apr; ():. PubMed ID: 19552552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
    Thoma K; Bechtold K
    Eur J Pharm Biopharm; 1999 Jan; 47(1):39-50. PubMed ID: 10234526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parameters influencing polymer particle layering of the dry coating process.
    Kablitz CD; Kappl M; Urbanetz NA
    Eur J Pharm Biopharm; 2008 Jun; 69(2):760-8. PubMed ID: 18434111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.